These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Ward A; Chaffman MO; Sorkin EM Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659 [TBL] [Abstract][Full Text] [Related]
9. Malignant hyperpyrexia. Rosenburg H Am J Nurs; 1981 Aug; 81(8):1484-6. PubMed ID: 6910989 [No Abstract] [Full Text] [Related]
10. Malignant hyperpyrexia. Denborough MA Med J Aust; 1977 Dec; 2(23):757-8. PubMed ID: 611371 [No Abstract] [Full Text] [Related]
11. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. Harrison GG Br J Anaesth; 1975 Jan; 47(1):62-5. PubMed ID: 1148076 [TBL] [Abstract][Full Text] [Related]
12. Fatal thermal injury. Denborough M Med J Aust; 1989 May; 150(10):608. PubMed ID: 2716576 [No Abstract] [Full Text] [Related]
13. The pathopharmacology of malignant hyperpyrexia. Denborough MA Pharmacol Ther; 1980; 9(3):357-65. PubMed ID: 6997892 [No Abstract] [Full Text] [Related]
14. [Malignant hyperthermia]. Grote B Anaesthesist; 1980 Feb; 29(2):53-4. PubMed ID: 7377524 [No Abstract] [Full Text] [Related]